Dr. Julia Lewis, MD
Nephrology (Kidney) (Nephrology Physician)
- Medicare participating
At a glance
- Medical school
- University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) (1980)
- Years since graduation
- 46
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 326
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1980Medical school: University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb)
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
TN license MD16829
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Vanderbilt University Medical Center Nashville, TN
- Vanderbilt Wilson County Hospital Lebanon, TN
Medical groups
- Vanderbilt University Medical Center (3,567 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 326
- Services billed
- 1,120
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 267 | 104 |
| Established patient office or other outpatient visit, 30-39 minutes | 193 | 122 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 163 | 29 |
| Home dialysis services per month (20 years or older) | 120 | 20 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 87 | 85 |
| Hemodialysis procedure with physician evaluation | 54 | 24 |
| Dialysis procedure requiring repeat evaluation | 45 | 17 |
| Established patient office or other outpatient visit, 40-54 minutes | 38 | 29 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 30 | 14 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 20 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Calcium Acetate Other prescribers in Nashville, TN | 149 |
| Losartan Potassium Other prescribers in Nashville, TN | 134 |
| Nifedipine Er (nifedipine) Other prescribers in Nashville, TN | 68 |
| Furosemide Other prescribers in Nashville, TN | 65 |
| Sevelamer Carbonate Other prescribers in Nashville, TN | 60 |
| Lisinopril Other prescribers in Nashville, TN | 47 |
| Amlodipine Besylate Other prescribers in Nashville, TN | 46 |
| Calcitriol Other prescribers in Nashville, TN | 45 |
| Veltassa (patiromer calcium sorbitex) | 39 |
| Prednisone Other prescribers in Nashville, TN | 34 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 8 payments worth $19,681 in total to this clinician.
| Travere Therapeutics, Inc. | $13,223 |
|---|---|
| Ipsen Biopharmaceuticals, Inc | $5,575 |
| Biogen, Inc. | $750 |
| Calliditas Therapeutics US Inc. | $132 |
| Consulting Fee | $18,675 |
|---|---|
| Travel and Lodging | $873 |
| Food and Beverage | $132 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Travere Therapeutics, Inc. Sep 2, 2025 | Consulting Fee | $9,100 |
| Travere Therapeutics, Inc. May 23, 2025 | Consulting Fee | $3,250 |
| Ipsen Biopharmaceuticals, Inc May 14, 2025 | Consulting Fee | $3,020 |
| Ipsen Biopharmaceuticals, Inc Jun 4, 2025 | Consulting Fee | $1,800 |
| Travere Therapeutics, Inc. Sep 2, 2025 | Travel and Lodging travel to san diego, CA · in-kind | $873 |
| Ipsen Biopharmaceuticals, Inc May 14, 2025 | Consulting Fee | $755 |
| Biogen, Inc. Jun 12, 2025 | Consulting Fee | $750 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $2,723 in research payments for these studies, mostly to the institutions running them.
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Povetacicept in Adults With Immunoglobulin A Nephropathy (RAINIER)
Vertex Pharmaceuticals Incorporated
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.